SI-BONE, Inc.: BROWN ADVISORY INC amends Schedule 13G stake filing
Not investment advice. Muhabbit scores how much a story may matter, not which way to trade.
Brown Advisory Inc. amended its Schedule 13G filing on SI-BONE, Inc., updating its stake disclosure with the SEC under accession number 0001345929-26-000043. The filing concerns the medical device maker's Class A common stock, though the amended document did not immediately specify the exact size or percentage of the position. Schedule 13G amendments are typically filed by institutional investors to reflect changes in passive holdings above the 5% threshold. The update signals a shift in Brown Advisory's ownership interest in SI-BONE, which investors monitor for clues about institutional conviction in the small-cap orthopedic company. What to watch next is whether the amended filing discloses a stake increase or reduction, and whether other large holders follow with similar 13G updates.
Muhabbit's AI wrote this summary in its own words from SEC EDGAR SCHEDULE 13G's report. It can get details wrong, so check the source.
Named in this story
SI-BONE, Inc., Brown Advisory Inc